Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-08 Sale | 2023-11-13 2:51 pm | INTERCEPT PHARMACEUTICALS INC. | ICPT | AKKARAJU SRINIVAS Director | 8,111 | $19 | $154,109 | 0 (Indirect Direct) | View |
| 2023-11-08 Sale | 2023-11-13 2:49 pm | INTERCEPT PHARMACEUTICALS INC. | ICPT | Venezia Rocco Chief Accounting Officer | 14,669 | $19 | $278,711 | 0 (Direct) | View |
| 2023-11-08 Sale | 2023-11-13 2:49 pm | INTERCEPT PHARMACEUTICALS INC. | ICPT | Berrey M Michelle President, R&D and CMO | 51,790 | $19 | $984,010 | 0 (Direct) | View |
| 2023-11-08 Sale | 2023-11-13 2:47 pm | INTERCEPT PHARMACEUTICALS INC. | ICPT | Fundaro Paolo Director | 8,111 | $19 | $154,109 | 0 (Direct) | View |
| 2023-11-08 Sale | 2023-11-13 2:46 pm | INTERCEPT PHARMACEUTICALS INC. | ICPT | Richardson Linda M EVP & Chief Commercial Officer | 26,585 | $19 | $505,115 | 0 (Direct) | View |
| 2023-11-08 Sale | 2023-11-13 2:46 pm | INTERCEPT PHARMACEUTICALS INC. | ICPT | Benatti Luca Director | 8,111 | $19 | $154,109 | 0 (Direct) | View |
| 2023-11-08 Sale | 2023-11-13 2:45 pm | INTERCEPT PHARMACEUTICALS INC. | ICPT | SBLENDORIO GLENN Director | 8,111 | $19 | $154,109 | 0 (Direct) | View |
| 2023-11-08 Sale | 2023-11-13 2:44 pm | INTERCEPT PHARMACEUTICALS INC. | ICPT | SANTINI GINO Director | 8,111 | $19 | $154,109 | 0 (Direct) | View |
| 2023-11-08 Sale | 2023-11-13 2:44 pm | INTERCEPT PHARMACEUTICALS INC. | ICPT | Miller-Rich Nancy Director | 8,111 | $19 | $154,109 | 0 (Direct) | View |
| 2023-11-08 Sale | 2023-11-13 2:43 pm | INTERCEPT PHARMACEUTICALS INC. | ICPT | ROSA-BJORKESON DAGMAR Director | 11,625 | $19 | $220,875 | 0 (Direct) | View |
| 2023-11-08 Sale | 2023-11-13 2:43 pm | INTERCEPT PHARMACEUTICALS INC. | ICPT | Gottesdiener Keith Michael Director | 8,111 | $19 | $154,109 | 0 (Direct) | View |
| 2023-11-08 Sale | 2023-11-13 2:42 pm | INTERCEPT PHARMACEUTICALS INC. | ICPT | Ford David A Chief Human Resources Officer | 21,400 | $19 | $406,600 | 0 (Direct) | View |
| 2023-11-08 Sale | 2023-11-13 2:42 pm | INTERCEPT PHARMACEUTICALS INC. | ICPT | Freedberg Jared General Counsel | 33,762 | $19 | $641,478 | 0 (Direct) | View |
| 2023-11-08 Sale | 2023-11-13 2:41 pm | INTERCEPT PHARMACEUTICALS INC. | ICPT | BRADBURY DANIEL Director | 8,111 | $19 | $154,109 | 0 (Indirect Direct) | View |
| 2023-11-08 Sale | 2023-11-13 2:40 pm | INTERCEPT PHARMACEUTICALS INC. | ICPT | Durso Jerome Benedict CEO | 102,825 | $19 | $1,953,675 | 0 (Direct) | View |
| 2023-11-08 Sale | 2023-11-13 2:40 pm | INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer | 45,244 | $19 | $859,636 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-11-08 Equity Swap | 2023-11-13 2:51 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | AKKARAJU SRINIVAS Director | 678,575 | $19 | 0 (Direct) | View |
| 2023-11-08 Equity Swap | 2023-11-13 2:49 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Venezia Rocco Chief Accounting Officer | 10,782 | $19 | 0 (Direct) | View |
| 2023-11-08 Equity Swap | 2023-11-13 2:49 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Berrey M Michelle President, R&D and CMO | 28,349 | $19 | 0 (Direct) | View |
| 2023-11-08 Equity Swap | 2023-11-13 2:47 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Fundaro Paolo Director | 35,794 | $19 | 0 (Direct) | View |
| 2023-11-08 Equity Swap | 2023-11-13 2:46 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Richardson Linda M EVP & Chief Commercial Officer | 16,706 | $19 | 0 (Direct) | View |
| 2023-11-08 Equity Swap | 2023-11-13 2:46 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Benatti Luca Director | 25,487 | $19 | 0 (Direct) | View |
| 2023-11-08 Equity Swap | 2023-11-13 2:45 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | SBLENDORIO GLENN Director | 23,447 | $19 | 0 (Direct) | View |
| 2023-11-08 Equity Swap | 2023-11-13 2:44 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | SANTINI GINO Director | 23,645 | $19 | 0 (Direct) | View |
| 2023-11-08 Equity Swap | 2023-11-13 2:44 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Miller-Rich Nancy Director | 22,304 | $19 | 0 (Direct) | View |
| 2023-11-08 Equity Swap | 2023-11-13 2:43 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | ROSA-BJORKESON DAGMAR Director | 14,766 | $19 | 0 (Direct) | View |
| 2023-11-08 Equity Swap | 2023-11-13 2:43 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Gottesdiener Keith Michael Director | 24,719 | $19 | 0 (Direct) | View |
| 2023-11-08 Equity Swap | 2023-11-13 2:42 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Ford David A Chief Human Resources Officer | 15,038 | $19 | 0 (Direct) | View |
| 2023-11-08 Equity Swap | 2023-11-13 2:42 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Freedberg Jared General Counsel | 22,681 | $19 | 0 (Direct) | View |
| 2023-11-08 Equity Swap | 2023-11-13 2:41 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | BRADBURY DANIEL Director | 31,360 | $19 | 0 (Direct) | View |
| 2023-11-08 Equity Swap | 2023-11-13 2:40 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Durso Jerome Benedict CEO | 51,815 | $19 | 0 (Direct) | View |
| 2023-11-08 Equity Swap | 2023-11-13 2:40 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Pruzanski Mark Director | 618,894 | $19 | 0 (Direct) | View |
| 2023-11-08 Equity Swap | 2023-11-13 2:40 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer | 23,021 | $19 | 0 (Direct) | View |
| 2023-11-01 Tax Withholding | 2023-11-03 4:00 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Freedberg Jared General Counsel | 771 | $18.96 | 56,443 (Direct) | View |
| 2023-09-21 Tax Withholding | 2023-09-25 4:01 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer | 908 | $10.8 | 68,265 (Direct) | View |
| 2023-09-14 Tax Withholding | 2023-09-18 4:01 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Berrey M Michelle President, R&D & CMO | 1,246 | $11.57 | 80,139 (Direct) | View |
| 2023-08-01 Tax Withholding | 2023-08-03 4:01 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Freedberg Jared General Counsel | 771 | $10.5 | 57,214 (Direct) | View |
| 2023-06-21 Tax Withholding | 2023-06-23 4:04 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer | 908 | $11.74 | 69,173 (Direct) | View |
| 2023-06-14 Tax Withholding | 2023-06-16 4:01 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Berrey M Michelle President, R&D & CMO | 1,246 | $12.04 | 81,385 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-25 8:40 pm | N/A 2033-05-24 | INTERCEPT PHARMACEUTICALS INC. | ICPT | Benatti Luca Director | 20,658 | $0 | 46,145 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-25 8:40 pm | N/A 2033-05-24 | INTERCEPT PHARMACEUTICALS INC. | ICPT | SBLENDORIO GLENN Director | 20,658 | $0 | 44,105 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-25 8:40 pm | N/A 2033-05-24 | INTERCEPT PHARMACEUTICALS INC. | ICPT | Gottesdiener Keith Michael Director | 20,658 | $0 | 45,377 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-25 8:39 pm | N/A 2033-05-24 | INTERCEPT PHARMACEUTICALS INC. | ICPT | Fundaro Paolo Director | 20,658 | $0 | 56,452 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-25 8:39 pm | N/A 2033-05-24 | INTERCEPT PHARMACEUTICALS INC. | ICPT | SANTINI GINO Director | 20,658 | $0 | 44,303 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-25 8:39 pm | N/A 2033-05-24 | INTERCEPT PHARMACEUTICALS INC. | ICPT | ROSA-BJORKESON DAGMAR Director | 20,658 | $0 | 38,938 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-25 8:38 pm | N/A 2033-05-24 | INTERCEPT PHARMACEUTICALS INC. | ICPT | Miller-Rich Nancy Director | 20,658 | $0 | 42,962 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-25 8:37 pm | N/A 2033-05-24 | INTERCEPT PHARMACEUTICALS INC. | ICPT | BRADBURY DANIEL Director | 20,658 | $0 | 52,018 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-25 8:37 pm | N/A 2033-05-24 | INTERCEPT PHARMACEUTICALS INC. | ICPT | AKKARAJU SRINIVAS Director | 20,658 | $0 | 699,233 (Direct) | View |
| 2023-05-01 Tax Withholding | 2023-05-03 4:01 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Freedberg Jared General Counsel | 771 | $17.07 | 57,985 (Direct) | View |
| 2023-03-21 Tax Withholding | 2023-03-23 4:01 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer | 909 | $14.19 | 70,081 (Direct) | View |
| 2023-03-14 Tax Withholding | 2023-03-16 4:07 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Berrey M Michelle President, R&D & CMO | 1,246 | $15.79 | 82,631 (Direct) | View |
| 2023-02-14 Tax Withholding | 2023-02-16 4:01 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Richardson Linda M EVP & Chief Commercial Officer | 386 | $21.21 | 43,291 (Direct) | View |
| 2023-02-01 Tax Withholding | 2023-02-03 4:01 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Freedberg Jared General Counsel | 918 | $18.76 | 58,756 (Direct) | View |
| 2023-01-27 Option Award | 2023-01-31 4:06 pm | N/A 2033-01-27 | INTERCEPT PHARMACEUTICALS INC. | ICPT | Venezia Rocco Chief Accounting Officer | 25,800 | $0 | 41,451 (Direct) | View |
| 2023-01-27 Option Award | 2023-01-31 4:05 pm | N/A 2033-01-27 | INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer | 38,700 | $0 | 94,990 (Direct) | View |
| 2023-01-27 Option Award | 2023-01-31 4:05 pm | N/A 2033-01-27 | INTERCEPT PHARMACEUTICALS INC. | ICPT | Richardson Linda M EVP & Chief Commercial Officer | 32,200 | $0 | 63,677 (Direct) | View |